Athera Biotechnologies AB
PrivateLast Round
VC Round
May 21, 2019
Company Overview
Athera Biotechnologies AB is a biotechnology company that develops targeted anti-inflammatory biological candidate drugs for the prevention and treatment of cardiovascular and immunovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athera Biotechnologies AB Comparables
Compare Athera Biotechnologies AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abcentra | 84% | |
| Marea Therapeutics | 74% | |
| Beijing Sungen Biomedical Technology Co., Ltd. | 71% |
Athera Biotechnologies AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 21, 2019 | ||||
| VC Round | Aug 29, 2017 | ||||
| VC Round | Dec 3, 2015 |
Athera Biotechnologies AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Industrifonden | VC Round |
| The Foundation for Baltic and East European Studies | VC Round |
| Linc AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2017
$7M raised from Linc AB, Industrifonden, and others.
- Dec 3, 2015
$3M round led by Industrifonden and The Foundation for Baltic and East European Studies.
Athera Biotechnologies AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Athera Biotechnologies AB's valuation, stock price, and market status.
Is Athera Biotechnologies AB a public or private company?
Athera Biotechnologies AB is a private company.
What is the current stock price of Athera Biotechnologies AB?
Athera Biotechnologies AB is a private company with no public stock price. No recent secondary market data is available.
How much is Athera Biotechnologies AB worth (valuation)?
Valuation information for Athera Biotechnologies AB is not publicly available.
Can I buy Athera Biotechnologies AB stock?
Athera Biotechnologies AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Athera Biotechnologies AB's last funding round?
Athera Biotechnologies AB's most recent funding round was VC Round on May 21, 2019.
Who are the main investors in Athera Biotechnologies AB?
Key investors in Athera Biotechnologies AB include Industrifonden, The Foundation for Baltic and East European Studies.
Will Athera Biotechnologies AB IPO soon?
No public IPO plans have been announced for Athera Biotechnologies AB.
How can I track Athera Biotechnologies AB secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Athera Biotechnologies AB's secondary market activity and sign up for updates.